Dirk W. Kirsten
Förmögenhet: 635 428 $ per 2026-08-31
Förmögenhet: 635 428 $ per 2026-08-31
Dirk W.
Kirsten worked as Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004.
From 2004 to 2008, worked as Group Treasurer at Syngenta AG.
From 2008 to 2013, worked as Chief Financial Officer at Nobel Biocare Holding AG.
From 2021 to 2026, worked as Chief Financial Officer at Medartis Holding AG.
Dr. Kirsten earned a doctorate from Universität zu Köln.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
MEDARTIS HOLDING AG 0,04 % | 2025-12-31 | 5 762 ( 0,04 % ) | 635 428 $ | 2026-08-31 |
| Företag | Position | Slut |
|---|---|---|
| MEDARTIS HOLDING AG | Finansdirektör/CFO | 2026-01-01 |
| NOBEL BIOCARE HOLDING AG | Finansdirektör/CFO | 2013-01-01 |
| SYNGENTA | Treasurer | 2008-01-01 |
| ROCHE HOLDING AG | Företagsledare/Principal | 2004-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Syngenta AG
Syngenta AG Packaged SoftwareTechnology Services Develops technologies and farming practices | Technology Services |
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Manfuctures and markets dental equipment, supplies, implants and devices | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medartis Holding AG
Medartis Holding AG Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån